What Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions requires
This directive establishes the conditions under which biotechnological inventions are patentable in the European Union, including isolated gene sequences, provided they meet novelty, inventive step, and industrial applicability criteria under Article 53, and excludes patents on animal varieties, essentially biological processes, and uses of human embryos for industrial or commercial purposes under Article 6. It applies to patent applicants, biotech firms, research institutions, and EU national patent offices.
Pillar: Biotech & Genomics · Authority: European Parliament and Council of the European Union · Version: 1.0.0 · Last updated:
Primary source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A31998L0044
SHA-256 integrity: 13209e2141b4d70b51608d0c9db7269e603482cb27cf8b8d48a6bc186cf4a51c
Primary Citations — 7 traced to source
- Directive 98/44/EC, Article 3 - Patentable Inventions
- Directive 98/44/EC, Article 4 - Exclusion of Plant and Animal Varieties
+ 5 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/eu-biotech-directive-98-44-ec-patents.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/eu-biotech-directive-98-44-ec-patents.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/eu-biotech-directive-98-44-ec-patents
- Back to registry: Browse all 10,090 compliance nodes